UiPath stock today: PATH slips after CEO Daniel Dines share sales; S&P MidCap 400 debut ahead
1 January 2026
2 mins read

UiPath stock today: PATH slips after CEO Daniel Dines share sales; S&P MidCap 400 debut ahead

NEW YORK, January 1, 2026, 11:14 ET — Market closed

  • UiPath shares last closed down 1.8% at $16.39 on Wednesday.
  • SEC filing shows CEO Daniel Dines sold 90,000 shares under a pre-arranged plan.
  • UiPath is set to join the S&P MidCap 400 before Friday’s open.

UiPath, Inc. shares slipped 1.8% to $16.39 on Wednesday on volume of about 70 million shares, after trading between $16.27 and $16.74. A filing showed founder and CEO Daniel Dines sold 90,000 Class A shares on Dec. 30 and Dec. 31 under a Rule 10b5-1 plan, at weighted-average prices of $16.8211 and $16.5473. 1

The sales landed just ahead of a benchmark change that can amplify trading in individual names. UiPath is due to enter the S&P MidCap 400 on Friday, a shift that typically prompts passive funds to adjust holdings.

A Rule 10b5-1 plan is a preset trading program meant to let insiders buy or sell shares on a fixed schedule, helping avoid allegations of trading on material nonpublic information. Even so, investors often scrutinize insider transactions for signals on valuation and sentiment, particularly when they coincide with index reshuffles.

UiPath sells robotic process automation software that helps companies automate repetitive digital work, from invoice processing to customer onboarding. The company has been pitching what it calls agentic automation, blending AI models with rules-based workflows and orchestration.

Index additions can attract short-term demand because funds that track the benchmark must buy the stock, regardless of price. That dynamic can create volatility around the open and close as trading desks try to match index weights.

S&P Dow Jones Indices said UiPath will replace Synovus Financial in the S&P MidCap 400, as Synovus is being acquired by Pinnacle Financial Partners. The change is effective prior to the open on Jan. 2, S&P said. 2

On the research front, Zacks Equity Research highlighted UiPath on its Dec. 31 list of momentum stocks, saying upward revisions to earnings estimates supported its “strong buy” ranking. UiPath’s shares have gained about 24.5% over the past three months, Zacks said. 3

UiPath last reported results on Dec. 3, when it posted revenue of $411 million and annual recurring revenue (ARR) of $1.782 billion, and issued fourth-quarter guidance that called for revenue of $462 million to $467 million. It forecast ARR of $1.844 billion to $1.849 billion as of Jan. 31 and non-GAAP operating income of about $140 million; non-GAAP figures exclude certain expenses such as stock-based compensation. “Enterprises are accelerating their AI and automation strategies,” Dines said. 4

ARR, a standard subscription-software metric, is watched closely because it reflects contracted recurring revenue for the next year. Investors will also track UiPath’s dollar-based net retention rate — a measure of how much existing customers expand or shrink spending — as companies reassess IT budgets.

Before the next session, U.S. markets are closed on Thursday for the New Year’s Day holiday and reopen Friday. UiPath’s MidCap 400 debut will be an early test of whether index-driven demand can steady the stock as investors track progress toward the company’s ARR and profitability targets for the quarter. 5

Technically, traders are watching support near $16.27, Wednesday’s low, and resistance around $16.74, the session high. A move beyond that range could shape positioning into early January.

Macro data could also set the tone for risk appetite, with the ISM manufacturing PMI due at 10:00 a.m. ET on Friday and the U.S. jobs report scheduled for Jan. 9. UiPath has not confirmed its next earnings date, but some earnings calendars estimate March 11. 6

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Boeing stock today: Pentagon’s $2.7B Apache deal puts BA in focus heading into 2026
Previous Story

Boeing stock today: Pentagon’s $2.7B Apache deal puts BA in focus heading into 2026

Goldman Sachs stock today: GS ends 2025 lower as Wall Street turns to earnings and rates
Next Story

Goldman Sachs stock today: GS ends 2025 lower as Wall Street turns to earnings and rates

Go toTop